Mexico's COVID-19 Vaccination Drive: High Uptake of Pfizer and Moderna Boosters, Low Acceptance of Russian and Cuban Vaccines
Mexico's COVID-19 vaccination drive has seen high uptake among the elderly and those with underlying health conditions, with many opting for Pfizer and Moderna boosters. However, the acceptance of Russian and Cuban vaccines remains low due to concerns about their effectiveness and safety.
Despite Mexico procuring millions of doses of Russian Sputnik and Cuban Abdala vaccines, only around 1.9 million eligible individuals, or 9.5%, have chosen to receive them since October 2021. This low take-up rate is attributed to public distrust in these vaccines, stemming from their relative novelty and lack of extensive studies on their effectiveness against current variants.
In contrast, four out of five people who received influenza shots this year declined the government's recommendation to get Russian or Cuban COVID-19 boosters simultaneously. This suggests a preference for more established vaccines, such as those produced by Pfizer and Moderna, which have been designed to target the currently circulating COVID variants. However, Mexico has delayed approval for these boosters, potentially impacting their availability.
As of 2025, the use of Russian and Cuban COVID-19 booster vaccines remains limited outside their regions of origin. In Mexico, efforts to promote these vaccines have faced challenges due to public concerns about their safety and efficacy. To boost vaccination rates, addressing these concerns and expediting approval for established booster vaccines may be crucial.
Read also:
- Overweight women undergoing IVF have a 47% higher chance of conceiving naturally post-weight loss
- Bonsai Trees from Evergreen Species: Exploring Growth Characteristics & Distinct Qualities
- What temperatures may make walking your canine companion uncomfortable?
- Title: Information About Beovu: Potency, Form, Usage, and Additional Details
